Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

P O'Connor, G Comi, X Montalban, J Antel, E W Radue, A de Vera, H Pohlmann, L Kappos, Jette Lautrup Battistini, FTY720 D2201 Study Group

    167 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study'. Together they form a unique fingerprint.

    Medicine & Life Sciences